To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Thrombin-based hemostatic agent associated with reduced drain output & transfusion in TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2015

Thrombin-based hemostatic agent associated with reduced drain output & transfusion in TKA

Vol: 4| Issue: 3| Number:28| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy of intra-articular injection of thrombin-based hemostatic agent in the control of bleeding after primary total knee arthroplasty

Knee Surg Relat Res. 2014 Dec;26(4):236-40

Contributing Authors:
KC Bae CH Cho KJ Lee ES Son SW Lee SJ Lee KH Lim

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

100 patients scheduled for total knee arthroplasty were randomized to either receive or not receive intraoperative intraarticular administration of a thrombin-based hemostatic agent. The purpose of this study was to determine the efficacy of the thrombin-based hemostatic agent (Floseal, Baxter) on reducing blood loss following total knee arthroplasty. Drain output, hemoglobin (Hb) and hematocrit l...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue